These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25345436)

  • 1. Cardiac conduction disturbance after loperamide abuse.
    Marraffa JM; Holland MG; Sullivan RW; Morgan BW; Oakes JA; Wiegand TJ; Hodgman MJ
    Clin Toxicol (Phila); 2014 Nov; 52(9):952-7. PubMed ID: 25345436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not your regular high: cardiac dysrhythmias caused by loperamide.
    Wightman RS; Hoffman RS; Howland MA; Rice B; Biary R; Lugassy D
    Clin Toxicol (Phila); 2016 Jun; 54(5):454-8. PubMed ID: 27022002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected Serious Cardiac Arrhythmias in the Setting of Loperamide Abuse.
    Rasla S; Parikh P; Hoffmeister P; St Amand A; Garas MK; El Meligy A; Minami T; Shah NR
    R I Med J (2013); 2017 Apr; 100(4):33-36. PubMed ID: 28375418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loperamide Abuse Associated With Cardiac Dysrhythmia and Death.
    Eggleston W; Clark KH; Marraffa JM
    Ann Emerg Med; 2017 Jan; 69(1):83-86. PubMed ID: 27140747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loperamide misuse and abuse.
    Miller H; Panahi L; Tapia D; Tran A; Bowman JD
    J Am Pharm Assoc (2003); 2017; 57(2S):S45-S50. PubMed ID: 28189538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notes from the Field: Cardiac Dysrhythmias After Loperamide Abuse - New York, 2008-2016.
    Eggleston W; Marraffa JM; Stork CM; Mercurio-Zappala M; Su MK; Wightman RS; Cummings KR; Schier JG
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(45):1276-1277. PubMed ID: 27855148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loperamide toxicokinetics: serum concentrations in the overdose setting.
    Eggleston W; Nacca N; Marraffa JM
    Clin Toxicol (Phila); 2015 Jun; 53(5):495-6. PubMed ID: 25817442
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Review: Loperamide Toxicity.
    Wu PE; Juurlink DN
    Ann Emerg Med; 2017 Aug; 70(2):245-252. PubMed ID: 28506439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loperamide misuse to avoid opioid withdrawal and to achieve a euphoric effect: high doses and high risk.
    Lee VR; Vera A; Alexander A; Ruck B; Nelson LS; Wax P; Campleman S; Brent J; Calello DP
    Clin Toxicol (Phila); 2019 Mar; 57(3):175-180. PubMed ID: 30585509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse.
    Swank KA; Wu E; Kortepeter C; McAninch J; Levin RL
    J Am Pharm Assoc (2003); 2017; 57(2S):S63-S67. PubMed ID: 28073687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intentional Misuse and Abuse of Loperamide: A New Look at a Drug with "Low Abuse Potential".
    Borron SW; Watts SH; Tull J; Baeza S; Diebold S; Barrow A
    J Emerg Med; 2017 Jul; 53(1):73-84. PubMed ID: 28501383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loperamide: A Readily Available but Dangerous Opioid Substitute.
    White CM
    J Clin Pharmacol; 2019 Sep; 59(9):1165-1169. PubMed ID: 31116446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loperamide-Induced Torsades de Pointes: A Case Series.
    Katz KD; Cannon RD; Cook MD; Amaducci A; Day R; Enyart J; Burket G; Porter L; Roach T; Janssen J; Williams KE
    J Emerg Med; 2017 Sep; 53(3):339-344. PubMed ID: 28755998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular Dysrhythmias from Loperamide Misuse.
    Lasoff DR; Schneir A
    J Emerg Med; 2016 Mar; 50(3):508-9. PubMed ID: 26794455
    [No Abstract]   [Full Text] [Related]  

  • 15. Loperamide Trends in Abuse and Misuse Over 13 Years: 2002-2015.
    Lasoff DR; Koh CH; Corbett B; Minns AB; Cantrell FL
    Pharmacotherapy; 2017 Feb; 37(2):249-253. PubMed ID: 27995643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loperamide Abuse and Life-Threatening Arrhythmias: A Case Report and Literature Review.
    Caro MA; Shah SA; Jerry JM; Tesar GE; Khawam EA
    Psychosomatics; 2017; 58(4):441-445. PubMed ID: 28413089
    [No Abstract]   [Full Text] [Related]  

  • 17. Loperamide Cardiac Toxicity: Pathophysiology, Presentation, and Management.
    Wu PE; Juurlink DN
    Can J Cardiol; 2022 Sep; 38(9):1378-1383. PubMed ID: 35430193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular tachycardia associated with high-dose chronic loperamide use.
    Spinner HL; Lonardo NW; Mulamalla R; Stehlik J
    Pharmacotherapy; 2015 Feb; 35(2):234-8. PubMed ID: 25645123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loperamide Induced Life Threatening Ventricular Arrhythmia.
    Upadhyay A; Bodar V; Malekzadegan M; Singh S; Frumkin W; Mangla A; Doshi K
    Case Rep Cardiol; 2016; 2016():5040176. PubMed ID: 27547470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular Arrhythmias Associated With Over-the-Counter and Recreational Opioids.
    Krantz MJ; Rudo TJ; Haigney MCP; Stockbridge N; Kleiman RB; Klein M; Kao DP
    J Am Coll Cardiol; 2023 Jun; 81(23):2258-2268. PubMed ID: 37286256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.